{"disease":{"id":"solid-and-hematological-malignancies","name":"solid and hematological malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04944771","title":"Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04854681","title":"Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT03391791","title":"Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Adaptimmune","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}